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Abstract: Although there have been many studies that showed a close association between 
gastroesophageal reﬂ  ux disease (GERD) symptoms and chronic cough, it has been unknown 
whether acute cough is also associated with GERD. The aim of this study was to evaluate the 
relationship between GERD and respiratory symptoms in general practice. 1725 consecutive 
patients who ﬁ  rst attended our hospital were enrolled in the present study. They were asked 
to respond the F-scale questionnaire regardless of their chief complaints. Over all, 656 (38%) 
patients were diagnosed as GERD and 226 (13%) had respiratory symptoms. Patients with 
respiratory symptoms had GERD symptoms more frequently than patients without respiratory 
symptoms (p  0.05). Forty-three (37%) of 115 patients with acute cough and 48 (43%) of 
111 with nonacute cough had GERD symptoms, suggesting that development of GERD is not 
associated with the period of respiratory symptoms. Patients with respiratory symptoms are 
at a signiﬁ  cantly increased risk of developing GERD. Whether or not treatment for GERD or 
respiratory diseases is useful for the prevention of respiratory symptoms and GERD, respectively, 
should not be driving management decisions in primary care.
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Introduction
Symptoms of gastroesophageal reflux disease (GERD) are common, affecting 
10%–30% of the population in Western countries (Holtmann 2001). Recently, the 
prevalence of GERD is also increasing in a Japanese population with a high prevalence 
of atrophic gastritis (Furukawa et al 1999). Respiratory diseases are also common 
causes for consultation in primary care, but the association between the two diseases 
remains unclear. Many previous studies of the association between the two had 
selection bias since data were obtained in a retrospective manner. Studies addressing 
the correlation between respiratory disorders and GERD symptoms in an unselected 
group of persons are sparse. The incidence of chronic bronchitis, asthma, and chronic 
pulmonary disease is 1.5 times more in patients with reﬂ  ux esophagitis (el Serag 
and Sonnenberg 1997). Other studies demonstrated a high prevalence of GERD in 
asthmatic patients (Sontag et al 1990; Vaezi 2003). Thus, although there have been 
many studies that showed a close association between GERD symptoms and chronic 
cough, it has been unknown whether acute cough is also associated with GERD. The 
aim of this study was to evaluate the relationship between GERD and respiratory 
symptoms in general practice.
Patients and methods
Between September 2005 and March 2006, 1725 consecutive patients (788 men and 
937 women with a mean age of 42 years) who ﬁ  rst attended the Outpatient Department International Journal of General Medicine 2008:1 60
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of General Medicine and Emergency Care of Toho University 
Omori Hospital were enrolled in the present study. Informed 
consent was obtained from all of the patients. None of the 
patients had a history of use of proton pump inhibitor (PPI), 
H2-receptor antagonist, antibiotics, steroids, or nonsteroidal 
antiinﬂ  ammatory drugs for a period of at least two month 
before the investigation. Patients who had a previous history 
of partial gastrectomy were also excluded from the study. 
The study was carried out in accordance with the Declaration 
of Helsinki, and approved by the ethical committee at Toho 
University.
All of the patients who ﬁ  rst attended our hospital were 
asked to respond the F-scale questionnaire regardless of 
their chief complaints. The questionnaire is a self-report 
instrument containing 12 questions written in a simple 
and easy-to-understand language. As reported previously 
by Kusano and colleagues (2004), the following deﬁ  nitions 
were used to identify symptoms in the F-scale: 1) “Do you get 
heartburn?”; 2) “Does your stomach feel bloated?”; 3) “Does 
your stomach ever feel heavy after meals?”; 4) “Do you 
sometimes subconsciously rub your chest with your hand?”; 
5) “Do you ever feel sick after meals?”; 6) “Do you 
get heartburn after meals?”; 7) “Do you have an unusual sensation 
in your throat?”; 8) “Do you feel full while eating meals?”; 
9) “Do some things get stuck when you swallow?”; 10) “Do 
you get bitter liquid coming up into your throat?”; 11) “ Do 
you burp a lot?”; and 12) “Do you get heartburn if you bend 
over?” Symptoms frequency was measured on the following 
scale: never = 0; occasionally = 1; sometimes = 2; often = 3; 
and always = 4. If the patient has a score of more than 7 point, 
GERD is considered as positive.
When a patient complains of cough that has been present 
for less than 3 weeks, it is considered to be an acute cough 
according to the ACCP evidence-based clinical practice 
guidelines (Braman 2006). When the cough lasts for more 
than 3 weeks, it is diagnosed as having nonacute cough in 
the present study.
All values are expressed as means ± SD. Comparisons of 
groups were made using Student’s t test or chi-square tests as 
appropriate. A p value of 0.05 was accepted as indicating 
statistical signiﬁ  cance.
Results
Over all, 656 (38%) patients were diagnosed as GERD and 226 
(13%) had respiratory symptoms including cough, sputum, and/
or dyspnea. GERD symptoms were found in 104 of  226 patients 
with respiratory symptoms and in 552 of 1499 patients without 
respiratory symptoms. Patients with respiratory symptoms 
had GERD symptoms more frequently than patients without 
respiratory symptoms with a statistical signiﬁ  cance (p  0.01, 
Table 1). F-scale score is signiﬁ  cantly higher in patients with 
respiratory symptoms (7.3 ± 6.2) than in those without respira-
tory symptoms (4.4 ± 5.8) (p  0.01). There were no signiﬁ  cant 
differences in age, male to female ratio, or the prpprtion of 
hypertension treated and current smokers between patients with 
and without respiratory symptoms (Table 1).
Among 226 patients with respiratory symptoms, 115 were 
diagnosed as acute cough and had a F-scale score of 6.8 ± 6.3. 
The remaining 111 patients were considered as having non-
acute cough and had a F-scale score of 7.7 ± 6.1. There was no 
signiﬁ  cant difference in F-scale score between the two groups. 
43 (37%) of 115 patients with acute cough and 48 (43%) of 
111 with nonacute cough had GERD symptoms (Table 2). The 
difference in prevalence of GERD between acute and nonacute 
cough groups did not reach statistical signiﬁ  cance.
GERD prevalence was analyzed after excluding 
pharyngeal symptoms because F-scale includes a question 
about an unusual sensation in the throat (question 7). Com-
parison of GERD prevalence between patients with and 
without pharyngeal symptoms was shown in Table 3. In 
patients with nonacute cough, those were found in 15 (60%) 
of 25 patients with pharyngeal symptoms and in 32 (38%) of 
85 without them. For acute cough, 22 (42%) of 53 patients 
with pharyngeal symptoms, and 18 (31%) of 58 patients 
without pharyngeal symptoms were diagnosed as GERD. 
The differences in GERD prevalence between patients with 
and without pharyngeal symptoms did not reach a statistical 
signiﬁ  cance in acute and nonacute cough groups.
Discussion
GERD refers to the abnormal exposure of the esophageal 
mucosa to gastric contents. Several population based-surveys 
Table 1 Comparison of GERD prevalence and F-scale score between 
patients with and without respiratory symptoms
  Respiratory symptoms  p-value
(+)( −)
No. of patient 226 1499
Age (years old) 41.9 ± 9.1 43.1 ± 8.5 N.S.
Male:Female 96:132 692:805 N.S.
Current smoker 79 (35%) 485 (32%)  N.S.
Hypertension 17 (8%) 111 (7%) N.S.
F-scale score 7.3 ± 6.2 4.4 ± 5.8 p  0.01
No. of GERD  104 (46%)  552 (37%) p  0.01
Abbreviation: GERD, gastroesophageal reﬂ  ux disease.International Journal of General Medicine 2008:1 61
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have reported typical GERD symptoms, including heartburn 
and acid regurgitation, at least yearly ranging from 26% 
to 60% (Ruth et al 1991; Staghellini et al 1999; Kennedy 
and Jones 2000; Diaz-Rubi et al 2004). These results are 
concordant with our ﬁ  ndings although GERD symptoms in the 
general population are less common in the East compared to 
the West (Ho et al 2005; Chen et al 2005). Since Helicobacter 
pylori infection may result in hypochlorhydria as seen in 
individuals with atrophic gastritis, H. pylori-infected patients 
seem to be at less risk of developing GERD (Mishima et al 
2005), as is generally observed in Japan with high prevalence 
of H. pylori infection. Recently, several reports showed an 
increasing trend of GERD in Asian countries in recent years 
(Ho et al 2005; Chen et al 2005; Lim et al 2005). Although it 
has been thought that a low acid secretion would be associated 
with a lower prevalence of GERD in the Far East, Kinoshita 
and colleagues (1997) demonstrated that gastric acid secretion 
in Japan is rising in both H. pylori-positive and – negative 
individuals. Actually, decreasing prevalence of H. pylori was 
observed in many countries (Banatvala et al 1993; Kosunen 
et al 1997; Roosendaal et al 1997) as well as in Japan (Asaka 
et al 1992).
On the other hand, there have been many studies that 
showed a close association between GERD symptoms and 
chronic cough (Sontag et al 1990; el Serag and Sonnenberg 
1997; Vaezi 2003). Several possible mechanisms underlying 
a relation between GERD and respiratory symptoms have 
been proposed.
Two mechanisms have been postulated by which GERD 
may induce cough: ﬁ  rstly, microaspiration of gastric reﬂ  uxate 
into the lung causing an exudative mucosal reaction; and 
secondly, a vagally mediated distal esophageal-tracheobronchial 
reﬂ  ex leading to bronchospasm (Ing et al 1994). The foregut 
and the respiratory tract have common embryological origins 
and share a number of reﬂ  exes. The existence of a vagally 
mediated esophageal-tracheobronchial reﬂ  ex could explain 
asthma worsening after a large meal (Pellicano et al 2005). 
Microaspiration has also been proposed as a cause of GERD 
induced bronchospasm. In guinea pig model, acid perfusion 
of the esophagus caused neurally mediated airway inﬂ  am-
mation (Ricciardolo et al 2004). The intimate mechanisms of 
acid-induced airway obstruction are dependent on activation 
of capsaicin-sensitive sensory nerves, with the subsequent 
release of tachykinins, that modulate diverse aspects of airway 
dysfunction (Ricciardolo et al 2004). Wilson and colleagues 
(1987) demonstrated direct evidence that ingestion of 200 mL 
of 0.1 N Hcl increased bronchial activity. Field and colleagues 
(1988) reported increased minute ventilation due to sensations 
of discomfort during acid perfusion of the esophagus in 
patients with normal lung function. Thus, heightened bronchial 
reactivity, microaspiration, and a vagally mediated reﬂ  ex 
mechanism are possible pathways.
The increased respiratory effort and cough augment 
abdominal pressure facilitating the retrograde movement of 
gastric contents (Field et al 2001). Changes in lung volume 
may alter the relationship between the diaphragm and lower 
esophageal sphincter (LES) disrupting the physiological 
activity (Stein et al 1980). The effect of asthma medications 
as well as the negative intrathoracic pressure produces during 
the asthma attacks may overcome the protective effect of the 
LES, resulting in increased GERD (Vaezi 2003). Theophylline, 
a bronchodilator, has been shown to stimulate gastric acid 
secretion and lower the LES pressure (Harding 2001). Exposure 
to small amounts of acid has been proposed to result in 
impaired laryngopharyngeal sensitivity and thereby potentially 
increasing the risk of aspiration (Harding 2001). Using 
prolonged esophageal pH monitoring, chronic persistent cough 
without obvious pulmonary etiology was likely to be associated 
with episodes of otherwise asymptomatic gastroesophageal 
reﬂ  ux (Phua et al 2005). Likewise, cough from any cause can 
precipitate gastroesophageal reﬂ  ux (Ing et al 1991). From these 
viewpoints, the present study on relationship between GERD 
symptoms and acute cough was proposed.
Similarly to the results of previous studies (Sontag et al 
1990; el Serag and Sonnenberg 1997; Vaezi 2003), patients 
with respiratory symptoms had GERD symptoms more 
frequently than patients without respiratory symptoms with 
a statistical signiﬁ  cance in the present study. Although the 
Table 2 Comparison of GERD prevalence and F-scale score between 
patients with and acute and nonacute cough
Acute cough Nonacute cough p-value
No. of patient 115 111
F-scale score 6.8 +/− 6.3 7.7 +/− 6.1 N.S.
No. of GERD 43 (37%) 48 (43%) N.S.
Abbreviation: GERD, gastroesophageal reﬂ  ux disease.
Table 3 The GERD prevalence in patients with and without pharyngeal 
symptoms in acute and nonacute cough groups
Nonacute cough Acute cough
Pharyngeal 
symptom
(+)( −)( +)( −)
No. of patient 25 85 53 58
No. of GERD 15 (60%) 32 (38%) 22 (42%) 18 (31%)
Abbreviation: GERD, gastroesophageal reﬂ  ux disease.International Journal of General Medicine 2008:1 62
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GERD prevalence is higher in patients with nonacute cough 
than in those with acute cough, there was no signiﬁ  cant 
difference. This suggests that even acute cough can cause 
an increase in intra-abdominal pressure which in turn may 
promote movement of gastric contents into the esophagus. 
It seems unlikely that GERD might cause acute cough 
because GERD is a chronic disease. Cough induced by 
GERD should be prolonged. Avidan and colleagues (2001) 
investigated the temporal association between coughing or 
wheezing and reﬂ  ux episodes in asthmatics and concluded 
that even though occasional coughing can lead to reﬂ  ux, 
the opposite is far more common. Some patients sometimes 
complain of a persistent cough following symptoms of an 
upper respiratory tract infection in clinical practice. When 
cough has been present for at least 3 weeks, but not more 
than 8 weeks, a diagnosis of postinfectious cough should be 
considered (Braman 2006). The frequency of postinfectious 
cough increases to 25% to 50% (Davis et al 1995) and 
gastroesophageal reflux is considered to be one of its 
mechanisms, suggesting that medical treatment of acid reﬂ  ux 
in acute phase of cough may reduce postinfectious cough 
although the pathogenesis is often multifactorial.
An epidemiological study on GERD could be considered 
accurate only when the whole study population undergoes 
invasive procedure. However, this would dramatically reduce 
the number of participants and prejudice the response rate of 
the study. F-scale, therefore, seems to be the most appropriate 
test for general practice patients in the management of GERD 
because it has made no use of endoscopy. F-scale covers 
various symptoms related to functional dyspepsia, as well 
as GERD. Among 12 questions in F-scale, the question 7 is 
closely related to sore throat, which is one of the most common 
symptoms observed in patients with an upper respiratory tract 
infection. It is likely that GERD prevalence in patients with 
acute cough is inﬂ  uenced by the presence of sore throat. We 
therefore analyzed the GERD prevalence after excluding the 
question 7, and there were no differences in GERD prevalence 
between patients with and without pharyngeal symptoms in 
acute and nonacute cough groups. This indicates that sore 
throat does not affect the results of this study.
In conclusion, patients with respiratory symptoms are at a 
signiﬁ  cantly increased risk of developing GERD. There was 
no difference in GERD prevalence between patients with 
acute and nonacute cough, suggesting that development of 
GERD is associated with the presence of respiratory diseases 
regardless of the period of respiratory symptoms. It is more 
important that the association between GERD and acute cough 
be more widely recognized in the primary care physicians.
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